Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 218220

In scope icon L 2
QID 218220 (Type "218220" in App Search)
You are involved in a clinical trial for a new drug for the management of rheumatoid arthritis. While early data suggests a substantial mortality and morbidity benefit, the drug does have unpleasant side effects. As a result, it is paramount that you ensure that the individuals who receive said drug actually have rheumatoid arthritis. In selecting a screening test, what measured value of the test should be highest in order to ensure that you do not accidentally treat individuals without rheumatoid arthritis?